Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
General Counsel
Anika Therapeutics, Inc. (ANIK)Equibles does not estimate personal net worth.
Get an email with a short summary when Anika Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ANIK alertsDavid B. Colleran is recorded as General Counsel at Anika Therapeutics, Inc. (ANIK). The newest filing on record that lists David B. Colleran as General Counsel at Anika Therapeutics, Inc. (ANIK) is dated April 28, 2026. The proxy statement of Anika Therapeutics, Inc. reports total compensation of $1,668,587 for David B. Colleran in fiscal 2024, including a base salary of $481,996. Disclosed compensation is on record for 7 fiscal years. Anika Therapeutics, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Anika Therapeutics, Inc. includes Cheryl Blanchard (CEO and Board Member), Stephen (Steve) Griffin (CEO and Board Member), Stephen D. Griffin (CEO, CFO and Board Member) and 7 others.
Start not stated–present
Last confirmed April 28, 2026
Drug Manufacturers - Specialty & Generic · Healthcare
General Counsel
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Anika Therapeutics, Inc. (ANIK) | General Counsel | $481,996 | $1,668,587 |
| 2023 | Anika Therapeutics, Inc. (ANIK) | General Counsel | $469,900 | $1,550,514 |
| 2022 | Anika Therapeutics, Inc. (ANIK) | General Counsel | $449,700 | $1,651,635 |
| 2021 | Anika Therapeutics, Inc. (ANIK) | General Counsel | $432,400 | $1,400,513 |
| 2020 | Anika Therapeutics, Inc. (ANIK) | EVP, General Counsel and Secretary | $344,077 | $1,705,616 |
| 2019 | Anika Therapeutics, Inc. (ANIK) | EVP, General Counsel and Secretary | — | — |
| 2018 | Anika Therapeutics, Inc. (ANIK) | EVP, General Counsel and Secretary | — | — |
No call appearances or filed executive changes recorded yet.